| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 108 | 2023 | 3157 | 7.230 |
Why?
|
| Mammography | 70 | 2019 | 475 | 4.840 |
Why?
|
| Artificial Intelligence | 25 | 2025 | 398 | 4.780 |
Why?
|
| Diagnosis, Computer-Assisted | 49 | 2025 | 341 | 4.170 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 57 | 2024 | 472 | 4.100 |
Why?
|
| Diagnostic Imaging | 20 | 2025 | 475 | 3.700 |
Why?
|
| Image Interpretation, Computer-Assisted | 31 | 2025 | 700 | 3.280 |
Why?
|
| Ultrasonography, Mammary | 20 | 2016 | 84 | 3.100 |
Why?
|
| Radiographic Image Enhancement | 68 | 2019 | 467 | 2.850 |
Why?
|
| Image Processing, Computer-Assisted | 49 | 2025 | 1319 | 2.840 |
Why?
|
| Breast | 16 | 2021 | 297 | 2.680 |
Why?
|
| Magnetic Resonance Imaging | 35 | 2025 | 3639 | 2.430 |
Why?
|
| ROC Curve | 67 | 2023 | 797 | 2.420 |
Why?
|
| Machine Learning | 12 | 2025 | 348 | 1.930 |
Why?
|
| Radiology | 12 | 2022 | 206 | 1.900 |
Why?
|
| Algorithms | 39 | 2025 | 2015 | 1.640 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2022 | 55 | 1.390 |
Why?
|
| Image Enhancement | 15 | 2018 | 565 | 1.280 |
Why?
|
| Humans | 241 | 2025 | 96105 | 1.270 |
Why?
|
| Brain Injuries | 2 | 2022 | 171 | 1.230 |
Why?
|
| Tomography, X-Ray Computed | 27 | 2025 | 2777 | 1.170 |
Why?
|
| Radiography, Thoracic | 27 | 2024 | 334 | 1.150 |
Why?
|
| Female | 141 | 2025 | 50028 | 1.110 |
Why?
|
| Lupus Nephritis | 5 | 2022 | 79 | 0.990 |
Why?
|
| Data Curation | 2 | 2025 | 10 | 0.980 |
Why?
|
| Radiography | 15 | 2018 | 826 | 0.940 |
Why?
|
| Health Information Interoperability | 1 | 2025 | 7 | 0.930 |
Why?
|
| Retrospective Studies | 36 | 2025 | 10287 | 0.920 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2015 | 166 | 0.910 |
Why?
|
| Pattern Recognition, Automated | 16 | 2013 | 223 | 0.880 |
Why?
|
| Thyroid Nodule | 1 | 2025 | 60 | 0.840 |
Why?
|
| Early Detection of Cancer | 6 | 2025 | 484 | 0.810 |
Why?
|
| Sensitivity and Specificity | 42 | 2024 | 2039 | 0.780 |
Why?
|
| Lymph Nodes | 3 | 2015 | 565 | 0.780 |
Why?
|
| Emphysema | 1 | 2023 | 24 | 0.760 |
Why?
|
| Middle Aged | 53 | 2025 | 28368 | 0.760 |
Why?
|
| Pulmonary Emphysema | 1 | 2023 | 43 | 0.750 |
Why?
|
| Health Physics | 5 | 2022 | 22 | 0.710 |
Why?
|
| Magnets | 1 | 2021 | 12 | 0.700 |
Why?
|
| Cells | 1 | 2021 | 31 | 0.690 |
Why?
|
| Radiometry | 4 | 2023 | 61 | 0.680 |
Why?
|
| Microscopy | 1 | 2021 | 91 | 0.670 |
Why?
|
| Calcaneus | 4 | 2010 | 41 | 0.650 |
Why?
|
| Adult | 49 | 2025 | 28721 | 0.650 |
Why?
|
| Organ Specificity | 1 | 2021 | 286 | 0.650 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1471 | 0.650 |
Why?
|
| Aged | 44 | 2025 | 20968 | 0.640 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 103 | 0.630 |
Why?
|
| Breast Diseases | 14 | 2018 | 101 | 0.630 |
Why?
|
| Medical Informatics | 2 | 2024 | 48 | 0.610 |
Why?
|
| Physics | 2 | 2018 | 21 | 0.590 |
Why?
|
| Risk Assessment | 7 | 2019 | 2480 | 0.570 |
Why?
|
| Heart Arrest | 1 | 2022 | 312 | 0.570 |
Why?
|
| Research Report | 1 | 2018 | 43 | 0.560 |
Why?
|
| Databases, Factual | 11 | 2018 | 1010 | 0.540 |
Why?
|
| Societies, Scientific | 1 | 2018 | 43 | 0.540 |
Why?
|
| Radiotherapy | 2 | 2020 | 328 | 0.540 |
Why?
|
| Mammary Glands, Human | 2 | 2014 | 26 | 0.530 |
Why?
|
| Societies, Medical | 3 | 2024 | 644 | 0.530 |
Why?
|
| Axilla | 2 | 2014 | 110 | 0.520 |
Why?
|
| Aged, 80 and over | 25 | 2019 | 7229 | 0.520 |
Why?
|
| Contrast Media | 15 | 2021 | 1096 | 0.520 |
Why?
|
| Reproducibility of Results | 29 | 2022 | 2880 | 0.520 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 186 | 0.520 |
Why?
|
| Lung Neoplasms | 14 | 2025 | 2463 | 0.510 |
Why?
|
| Lung | 15 | 2024 | 1384 | 0.490 |
Why?
|
| False Positive Reactions | 23 | 2014 | 222 | 0.480 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 514 | 0.470 |
Why?
|
| Biomedical Research | 5 | 2012 | 441 | 0.470 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2014 | 630 | 0.470 |
Why?
|
| Calcinosis | 16 | 2010 | 232 | 0.460 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 85 | 0.450 |
Why?
|
| Genes, BRCA2 | 3 | 2014 | 162 | 0.440 |
Why?
|
| Genes, BRCA1 | 4 | 2014 | 192 | 0.440 |
Why?
|
| Genomics | 2 | 2019 | 857 | 0.420 |
Why?
|
| Absorptiometry, Photon | 5 | 2007 | 110 | 0.410 |
Why?
|
| Diagnosis, Differential | 16 | 2018 | 1619 | 0.410 |
Why?
|
| Carcinoma | 2 | 2016 | 448 | 0.390 |
Why?
|
| Neoplasms | 6 | 2020 | 3248 | 0.390 |
Why?
|
| Area Under Curve | 14 | 2014 | 340 | 0.380 |
Why?
|
| Breast Density | 4 | 2019 | 37 | 0.380 |
Why?
|
| Artifacts | 5 | 2018 | 252 | 0.380 |
Why?
|
| Solitary Pulmonary Nodule | 8 | 2002 | 139 | 0.370 |
Why?
|
| Radiography, Interventional | 5 | 2016 | 154 | 0.350 |
Why?
|
| Subtraction Technique | 9 | 2011 | 130 | 0.350 |
Why?
|
| Observer Variation | 16 | 2024 | 626 | 0.350 |
Why?
|
| Catheterization | 4 | 2016 | 238 | 0.330 |
Why?
|
| User-Computer Interface | 3 | 2010 | 196 | 0.330 |
Why?
|
| Ultrasonography | 6 | 2025 | 744 | 0.330 |
Why?
|
| Bone Density | 11 | 2010 | 239 | 0.330 |
Why?
|
| Biopsy | 11 | 2021 | 1220 | 0.320 |
Why?
|
| Phenotype | 8 | 2022 | 2578 | 0.320 |
Why?
|
| Movement | 3 | 2007 | 324 | 0.320 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 422 | 0.300 |
Why?
|
| Tumor Burden | 3 | 2019 | 322 | 0.290 |
Why?
|
| Pilot Projects | 9 | 2025 | 938 | 0.270 |
Why?
|
| Signal-To-Noise Ratio | 3 | 2018 | 115 | 0.270 |
Why?
|
| Predictive Value of Tests | 7 | 2018 | 1805 | 0.260 |
Why?
|
| Radiologists | 2 | 2024 | 54 | 0.240 |
Why?
|
| Information Dissemination | 2 | 2025 | 126 | 0.240 |
Why?
|
| Technology, Radiologic | 9 | 1996 | 104 | 0.230 |
Why?
|
| Male | 28 | 2025 | 45863 | 0.230 |
Why?
|
| Mass Screening | 7 | 2025 | 710 | 0.230 |
Why?
|
| Data Collection | 2 | 2013 | 381 | 0.230 |
Why?
|
| Biological Science Disciplines | 1 | 2025 | 14 | 0.230 |
Why?
|
| Mutation | 6 | 2015 | 4374 | 0.230 |
Why?
|
| Adnexal Diseases | 1 | 2025 | 22 | 0.230 |
Why?
|
| Gastrostomy | 2 | 2016 | 69 | 0.220 |
Why?
|
| Catheters | 2 | 2016 | 90 | 0.220 |
Why?
|
| Fetus | 2 | 2023 | 239 | 0.220 |
Why?
|
| Precision Medicine | 2 | 2019 | 454 | 0.210 |
Why?
|
| Biomarkers | 4 | 2022 | 1930 | 0.210 |
Why?
|
| Head Injuries, Penetrating | 1 | 2025 | 67 | 0.210 |
Why?
|
| Neuroimaging | 1 | 2025 | 135 | 0.210 |
Why?
|
| Catheters, Indwelling | 2 | 2014 | 113 | 0.200 |
Why?
|
| Hydronephrosis | 1 | 2023 | 30 | 0.200 |
Why?
|
| Software | 11 | 2023 | 698 | 0.200 |
Why?
|
| Wounds, Gunshot | 1 | 2025 | 121 | 0.190 |
Why?
|
| Computer Simulation | 7 | 2014 | 1158 | 0.190 |
Why?
|
| Technology Assessment, Biomedical | 3 | 2012 | 27 | 0.190 |
Why?
|
| Phantoms, Imaging | 7 | 2023 | 490 | 0.190 |
Why?
|
| Lung Diseases | 8 | 2024 | 290 | 0.190 |
Why?
|
| Forecasting | 3 | 2020 | 317 | 0.190 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2025 | 259 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2025 | 374 | 0.180 |
Why?
|
| Coma | 1 | 2021 | 52 | 0.180 |
Why?
|
| Young Adult | 9 | 2025 | 7025 | 0.180 |
Why?
|
| Heart | 3 | 2010 | 591 | 0.170 |
Why?
|
| Osteoporosis | 5 | 2010 | 131 | 0.170 |
Why?
|
| NADP | 1 | 2021 | 49 | 0.170 |
Why?
|
| Models, Statistical | 6 | 2008 | 594 | 0.170 |
Why?
|
| Hormones | 1 | 2021 | 144 | 0.170 |
Why?
|
| Data Mining | 2 | 2018 | 44 | 0.170 |
Why?
|
| Radiation Oncology | 1 | 2022 | 124 | 0.170 |
Why?
|
| Information Storage and Retrieval | 5 | 2025 | 127 | 0.160 |
Why?
|
| Adaptive Immunity | 2 | 2019 | 180 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2025 | 4671 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2021 | 172 | 0.160 |
Why?
|
| Radiation Dosage | 6 | 2025 | 236 | 0.160 |
Why?
|
| Angiography | 7 | 1995 | 209 | 0.160 |
Why?
|
| Risk Factors | 10 | 2014 | 5961 | 0.160 |
Why?
|
| Education, Medical | 1 | 2022 | 252 | 0.150 |
Why?
|
| Parenchymal Tissue | 1 | 2019 | 7 | 0.150 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 17 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 202 | 0.150 |
Why?
|
| Bayes Theorem | 7 | 2013 | 404 | 0.150 |
Why?
|
| Gadolinium DTPA | 5 | 2014 | 255 | 0.140 |
Why?
|
| Television | 4 | 1986 | 29 | 0.140 |
Why?
|
| Documentation | 2 | 2010 | 103 | 0.140 |
Why?
|
| Adolescent | 8 | 2025 | 9895 | 0.140 |
Why?
|
| Pandemics | 2 | 2021 | 880 | 0.140 |
Why?
|
| Osteolysis | 2 | 2008 | 15 | 0.140 |
Why?
|
| Workflow | 1 | 2018 | 80 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 432 | 0.140 |
Why?
|
| Densitometry | 3 | 2010 | 28 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2020 | 369 | 0.130 |
Why?
|
| Computer Systems | 4 | 2000 | 79 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2860 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2018 | 192 | 0.130 |
Why?
|
| Kidney | 3 | 2022 | 1137 | 0.130 |
Why?
|
| Models, Theoretical | 7 | 2009 | 503 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 1998 | 154 | 0.130 |
Why?
|
| Likelihood Functions | 3 | 2013 | 257 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2018 | 327 | 0.120 |
Why?
|
| Nephritis, Interstitial | 1 | 2016 | 44 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2018 | 229 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2008 | 99 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2019 | 2474 | 0.120 |
Why?
|
| Teleradiology | 1 | 1996 | 4 | 0.120 |
Why?
|
| Time Factors | 8 | 2015 | 5580 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 1670 | 0.120 |
Why?
|
| Inflammation | 3 | 2022 | 1063 | 0.120 |
Why?
|
| Evaluation Studies as Topic | 11 | 2012 | 271 | 0.120 |
Why?
|
| United States | 7 | 2022 | 7768 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1196 | 0.120 |
Why?
|
| X-Ray Intensifying Screens | 5 | 1993 | 34 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 207 | 0.110 |
Why?
|
| Biophysical Phenomena | 12 | 2000 | 125 | 0.110 |
Why?
|
| Biophysics | 12 | 2000 | 157 | 0.110 |
Why?
|
| Femur Neck | 5 | 2006 | 44 | 0.110 |
Why?
|
| Prognosis | 4 | 2018 | 4028 | 0.110 |
Why?
|
| Device Approval | 2 | 2012 | 14 | 0.110 |
Why?
|
| Cardiomegaly | 2 | 2014 | 122 | 0.110 |
Why?
|
| Colonic Diseases | 1 | 2015 | 61 | 0.110 |
Why?
|
| Fourier Analysis | 7 | 2014 | 128 | 0.110 |
Why?
|
| Manganese | 1 | 2014 | 57 | 0.110 |
Why?
|
| Kinetics | 3 | 2013 | 1562 | 0.110 |
Why?
|
| Probability | 3 | 2014 | 365 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.110 |
Why?
|
| Atherosclerosis | 2 | 2007 | 267 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2019 | 541 | 0.110 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 6 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2016 | 489 | 0.110 |
Why?
|
| Primary Health Care | 1 | 1998 | 391 | 0.110 |
Why?
|
| Fuzzy Logic | 4 | 2010 | 16 | 0.110 |
Why?
|
| Datasets as Topic | 1 | 2014 | 82 | 0.110 |
Why?
|
| Thorax | 1 | 2014 | 80 | 0.110 |
Why?
|
| Sutures | 1 | 2014 | 59 | 0.100 |
Why?
|
| Apoptosis | 2 | 2019 | 1756 | 0.100 |
Why?
|
| Biomechanical Phenomena | 3 | 2013 | 506 | 0.100 |
Why?
|
| Holistic Health | 1 | 1993 | 9 | 0.100 |
Why?
|
| Gene Expression | 2 | 2016 | 1320 | 0.100 |
Why?
|
| Philosophy, Medical | 1 | 1993 | 17 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 120 | 0.100 |
Why?
|
| Risk | 2 | 2013 | 668 | 0.100 |
Why?
|
| Heterozygote | 1 | 2014 | 382 | 0.100 |
Why?
|
| Expert Systems | 1 | 1993 | 18 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2014 | 236 | 0.100 |
Why?
|
| Confidence Intervals | 3 | 2012 | 220 | 0.100 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 1993 | 13 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1535 | 0.100 |
Why?
|
| Suture Techniques | 1 | 2014 | 143 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 151 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2022 | 1134 | 0.100 |
Why?
|
| Motion | 1 | 2013 | 99 | 0.100 |
Why?
|
| Discriminant Analysis | 6 | 2013 | 66 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2014 | 185 | 0.100 |
Why?
|
| Complementary Therapies | 1 | 1993 | 55 | 0.100 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 186 | 0.100 |
Why?
|
| Professional Competence | 1 | 2013 | 72 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2015 | 246 | 0.090 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 74 | 0.090 |
Why?
|
| Calcium | 2 | 2014 | 1205 | 0.090 |
Why?
|
| BRCA2 Protein | 5 | 2008 | 175 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 279 | 0.090 |
Why?
|
| Multimodal Imaging | 1 | 2013 | 115 | 0.090 |
Why?
|
| Educational Status | 1 | 2013 | 202 | 0.090 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 1798 | 0.090 |
Why?
|
| Attitude | 1 | 2013 | 137 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 1316 | 0.090 |
Why?
|
| X-Ray Film | 8 | 1994 | 37 | 0.090 |
Why?
|
| Preventive Health Services | 1 | 2011 | 39 | 0.090 |
Why?
|
| Linear Models | 2 | 2009 | 438 | 0.090 |
Why?
|
| Equipment Failure Analysis | 3 | 2010 | 91 | 0.080 |
Why?
|
| Genome, Human | 1 | 2015 | 824 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 79 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 298 | 0.080 |
Why?
|
| Radiology Information Systems | 5 | 1999 | 78 | 0.080 |
Why?
|
| Research Design | 1 | 2014 | 631 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2086 | 0.080 |
Why?
|
| Diagnostic Errors | 5 | 2002 | 159 | 0.080 |
Why?
|
| Animals | 5 | 2021 | 28891 | 0.080 |
Why?
|
| Anthropometry | 1 | 2010 | 78 | 0.080 |
Why?
|
| Spinal Fractures | 2 | 2010 | 103 | 0.080 |
Why?
|
| Quality of Life | 1 | 1998 | 1816 | 0.080 |
Why?
|
| Bone and Bones | 3 | 2000 | 280 | 0.080 |
Why?
|
| Chicago | 2 | 2012 | 1506 | 0.080 |
Why?
|
| Fractals | 6 | 2008 | 42 | 0.070 |
Why?
|
| Equipment Design | 4 | 2015 | 427 | 0.070 |
Why?
|
| Reference Standards | 2 | 2023 | 150 | 0.070 |
Why?
|
| BRCA1 Protein | 3 | 2008 | 216 | 0.070 |
Why?
|
| Automation | 5 | 2014 | 115 | 0.070 |
Why?
|
| Fractures, Bone | 3 | 2006 | 155 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 1989 | 123 | 0.070 |
Why?
|
| Fibrocystic Breast Disease | 2 | 2005 | 12 | 0.070 |
Why?
|
| Filtration | 2 | 2006 | 27 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2021 | 445 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 1089 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 1876 | 0.070 |
Why?
|
| Bias | 2 | 2014 | 139 | 0.060 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 33 | 0.060 |
Why?
|
| Logistic Models | 1 | 2010 | 1268 | 0.060 |
Why?
|
| Regression Analysis | 5 | 2010 | 599 | 0.060 |
Why?
|
| Metadata | 1 | 2025 | 3 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2005 | 92 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 3240 | 0.060 |
Why?
|
| Age Factors | 4 | 2014 | 1963 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 2011 | 217 | 0.050 |
Why?
|
| Computers | 3 | 2000 | 111 | 0.050 |
Why?
|
| Copying Processes | 2 | 1994 | 6 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 363 | 0.050 |
Why?
|
| Databases as Topic | 5 | 2002 | 96 | 0.050 |
Why?
|
| Biomedical Engineering | 1 | 2003 | 21 | 0.050 |
Why?
|
| Public Health | 1 | 2025 | 155 | 0.050 |
Why?
|
| Mathematics | 6 | 1995 | 191 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 301 | 0.050 |
Why?
|
| Genetic Carrier Screening | 1 | 2002 | 59 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 231 | 0.050 |
Why?
|
| Neoplasm Grading | 2 | 2016 | 404 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2023 | 191 | 0.050 |
Why?
|
| Abdomen | 1 | 2023 | 127 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2010 | 393 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2025 | 483 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 883 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2015 | 9175 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2021 | 103 | 0.040 |
Why?
|
| Incidence | 2 | 2012 | 1715 | 0.040 |
Why?
|
| United States Food and Drug Administration | 2 | 2012 | 147 | 0.040 |
Why?
|
| Colonic Polyps | 1 | 2001 | 137 | 0.040 |
Why?
|
| Ribs | 2 | 1998 | 50 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 311 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2002 | 382 | 0.040 |
Why?
|
| China | 1 | 2020 | 264 | 0.040 |
Why?
|
| Heart Rate | 2 | 2014 | 518 | 0.040 |
Why?
|
| Models, Structural | 3 | 1993 | 58 | 0.040 |
Why?
|
| Lasers | 3 | 1993 | 102 | 0.040 |
Why?
|
| Switzerland | 1 | 1998 | 19 | 0.040 |
Why?
|
| Absenteeism | 1 | 1998 | 10 | 0.040 |
Why?
|
| Visual Perception | 1 | 2022 | 339 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 436 | 0.040 |
Why?
|
| Liver | 2 | 2013 | 1238 | 0.040 |
Why?
|
| Life Change Events | 1 | 1998 | 50 | 0.030 |
Why?
|
| Somatoform Disorders | 1 | 1998 | 31 | 0.030 |
Why?
|
| Acceleration | 2 | 2007 | 20 | 0.030 |
Why?
|
| Diaphragm | 1 | 1998 | 75 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 196 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2017 | 137 | 0.030 |
Why?
|
| Mice, Inbred NZB | 1 | 2016 | 13 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 635 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 20 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 2017 | 52 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2016 | 25 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 2016 | 32 | 0.030 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 41 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2022 | 854 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 623 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 417 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 89 | 0.030 |
Why?
|
| Germinal Center | 1 | 2016 | 65 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2004 | 205 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 122 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 103 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 286 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1973 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 3363 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1645 | 0.030 |
Why?
|
| Diastole | 1 | 2014 | 147 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 930 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 24 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2016 | 337 | 0.030 |
Why?
|
| Brain | 1 | 2025 | 2482 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 38 | 0.030 |
Why?
|
| Models, Biological | 3 | 2006 | 1809 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 1997 | 235 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 45 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 379 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 580 | 0.030 |
Why?
|
| Colectomy | 1 | 2015 | 192 | 0.030 |
Why?
|
| Anthroposophy | 1 | 1993 | 1 | 0.030 |
Why?
|
| Homeopathy | 1 | 1993 | 1 | 0.030 |
Why?
|
| Chiropractic | 1 | 1993 | 2 | 0.030 |
Why?
|
| Mice | 2 | 2019 | 12537 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1993 | 10 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 134 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 460 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1993 | 40 | 0.020 |
Why?
|
| Multigene Family | 1 | 2014 | 213 | 0.020 |
Why?
|
| Acute Disease | 1 | 2015 | 872 | 0.020 |
Why?
|
| Cell Communication | 1 | 2014 | 221 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 3927 | 0.020 |
Why?
|
| Mass Chest X-Ray | 1 | 1992 | 5 | 0.020 |
Why?
|
| Risk Management | 1 | 2012 | 43 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1992 | 107 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1828 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 285 | 0.020 |
Why?
|
| Water | 1 | 2014 | 307 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 209 | 0.020 |
Why?
|
| Child | 1 | 2023 | 7625 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 1996 | 460 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 703 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 1218 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2012 | 102 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Spine | 1 | 1993 | 153 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1133 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1192 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 1991 | 28 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 591 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2016 | 1126 | 0.020 |
Why?
|
| Spectrum Analysis | 2 | 1991 | 121 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1011 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 1157 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2011 | 77 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 586 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 349 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 882 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2009 | 36 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2161 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 810 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2013 | 480 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1994 | 1957 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1881 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 771 | 0.020 |
Why?
|
| Biometry | 2 | 1986 | 72 | 0.020 |
Why?
|
| Xenon Radioisotopes | 2 | 2000 | 10 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 2000 | 13 | 0.020 |
Why?
|
| Urban Population | 1 | 2009 | 240 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1989 | 219 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2000 | 1010 | 0.020 |
Why?
|
| Lumbar Vertebrae | 2 | 2006 | 363 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2534 | 0.020 |
Why?
|
| Differential Threshold | 1 | 1987 | 13 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3489 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1990 | 434 | 0.020 |
Why?
|
| Electricity | 1 | 1987 | 26 | 0.020 |
Why?
|
| Heart Diseases | 1 | 1990 | 314 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 119 | 0.020 |
Why?
|
| Physical Phenomena | 1 | 1986 | 7 | 0.020 |
Why?
|
| Hip Joint | 1 | 2006 | 56 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2494 | 0.010 |
Why?
|
| Analog-Digital Conversion | 1 | 1984 | 9 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 592 | 0.010 |
Why?
|
| Weights and Measures | 1 | 1984 | 7 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1349 | 0.010 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 33 | 0.010 |
Why?
|
| Breast Cyst | 1 | 2004 | 4 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2005 | 152 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1990 | 1105 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2003 | 92 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1999 | 86 | 0.010 |
Why?
|
| Joint Diseases | 1 | 1999 | 48 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 157 | 0.010 |
Why?
|
| Femur | 1 | 2000 | 108 | 0.010 |
Why?
|
| Fibroadenoma | 1 | 1999 | 9 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2000 | 261 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 694 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 1096 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1998 | 46 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 553 | 0.010 |
Why?
|
| Information Systems | 1 | 1995 | 30 | 0.010 |
Why?
|
| Printing | 1 | 1994 | 4 | 0.010 |
Why?
|
| Mediastinum | 1 | 1994 | 48 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1993 | 68 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1993 | 261 | 0.010 |
Why?
|
| Databases, Bibliographic | 1 | 1991 | 17 | 0.010 |
Why?
|
| Japan | 1 | 1992 | 313 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2000 | 1730 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1993 | 152 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1991 | 64 | 0.010 |
Why?
|
| Decision Trees | 1 | 1990 | 63 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1991 | 52 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1993 | 501 | 0.010 |
Why?
|
| Illinois | 1 | 1990 | 531 | 0.000 |
Why?
|
| Models, Anatomic | 1 | 1988 | 93 | 0.000 |
Why?
|
| Hand | 1 | 1988 | 168 | 0.000 |
Why?
|
| Decision Theory | 1 | 1986 | 3 | 0.000 |
Why?
|